CACNG6 | Calcium channel, voltage-dependent, gamma subunit 6 | Predicted membrane proteins Transporters
| | | | | Group enriched |
CACNG8 | Calcium channel, voltage-dependent, gamma subunit 8 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CALHM1 | Calcium homeostasis modulator 1 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CALHM2 | Calcium homeostasis modulator 2 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
CALHM3 | Calcium homeostasis modulator 3 | Predicted membrane proteins Transporters
| | | | | Not detected |
CD151 | CD151 molecule (Raph blood group) | Blood group antigen proteins CD markers Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
CD37 | CD37 molecule | CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CD47 | CD47 molecule | CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CD53 | CD53 molecule | CD markers Predicted membrane proteins
| | | | | Expressed in all |
CD63 | CD63 molecule | CD markers Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
CD81 | CD81 molecule | CD markers Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
CD82 | CD82 molecule | Cancer-related genes CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CD9 | CD9 molecule | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
CDAN1 | Codanin 1 | Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CERS2 | Ceramide synthase 2 | Predicted membrane proteins
| | | | | Expressed in all |
CERS4 | Ceramide synthase 4 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CERS5 | Ceramide synthase 5 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
CHRFAM7A | CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion | FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
CHRNA1 | Cholinergic receptor, nicotinic, alpha 1 (muscle) | Disease related genes Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CHRNA10 | Cholinergic receptor, nicotinic, alpha 10 (neuronal) | FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
CHRNA2 | Cholinergic receptor, nicotinic, alpha 2 (neuronal) | Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
CHRNA3 | Cholinergic receptor, nicotinic, alpha 3 (neuronal) | FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
CHRNA4 | Cholinergic receptor, nicotinic, alpha 4 (neuronal) | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CHRNA5 | Cholinergic receptor, nicotinic, alpha 5 (neuronal) | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
CHRNA6 | Cholinergic receptor, nicotinic, alpha 6 (neuronal) | Predicted intracellular proteins Predicted membrane proteins
| | | | | Not detected |
CHRNA7 | Cholinergic receptor, nicotinic, alpha 7 (neuronal) | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Mixed |
CHRNA9 | Cholinergic receptor, nicotinic, alpha 9 (neuronal) | Predicted membrane proteins
| | | | | Tissue enhanced |
CHRNB1 | Cholinergic receptor, nicotinic, beta 1 (muscle) | Disease related genes Potential drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
CHRNB2 | Cholinergic receptor, nicotinic, beta 2 (neuronal) | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CHRNB3 | Cholinergic receptor, nicotinic, beta 3 (neuronal) | Predicted intracellular proteins Predicted membrane proteins
| | | | | Not detected |
CHRNB4 | Cholinergic receptor, nicotinic, beta 4 (neuronal) | FDA approved drug targets Predicted membrane proteins
| | | | | Group enriched |
CHRND | Cholinergic receptor, nicotinic, delta (muscle) | Disease related genes Potential drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
CHRNE | Cholinergic receptor, nicotinic, epsilon (muscle) | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CHRNG | Cholinergic receptor, nicotinic, gamma (muscle) | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CKLF-CMTM1 | CKLF-CMTM1 readthrough | Predicted membrane proteins
| | | | | Mixed |
CLDN11 | Claudin 11 | Predicted membrane proteins
| | | | | Tissue enhanced |
CLDN12 | Claudin 12 | Predicted membrane proteins
| | | | | Expressed in all |
CLDN15 | Claudin 15 | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
CLDN16 | Claudin 16 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CLDN19 | Claudin 19 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
CLDN2 | Claudin 2 | Predicted membrane proteins
| | | | | Group enriched |
CLDN24 | Claudin 24 | Predicted membrane proteins
| | | | | Tissue enhanced |
CLDN3 | Claudin 3 | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
CLDN5 | Claudin 5 | Predicted membrane proteins
| | | | | Tissue enhanced |
CLDN8 | Claudin 8 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CLN3 | Ceroid-lipofuscinosis, neuronal 3 | Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CLN6 | Ceroid-lipofuscinosis, neuronal 6, late infantile, variant | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
CMTM1 | CKLF-like MARVEL transmembrane domain containing 1 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
CMTM2 | CKLF-like MARVEL transmembrane domain containing 2 | Predicted membrane proteins
| | | | | Tissue enriched |
CMTM4 | CKLF-like MARVEL transmembrane domain containing 4 | Predicted membrane proteins
| | | | | Tissue enhanced |